Brief: Elicera Therapeutics Q4 Operating Loss Narrows To SEK 2.14 Mln

Elicera Therapeutics AB

25/01/2022 07:11

Jan 25 (Reuters) - Elicera Therapeutics AB  ELIC.ST :
    * ELICERA THERAPEUTICS AB (PUBL) INTERIM REPORT 1 JANUARY -
31
DECEMBER 2021
    * Q4 OPERATING LOSS TOTALED SEK -2,142,267 (-2,596,526)
    * PROPOSED DIVIDEND OF SEK 0.00 PER SHARE (0.00 FOR
PRECEDING
YEAR)
    * Q4 LOSS FOR PERIOD TOTALED SEK -2,142,267 (-2,596,256)

Source text for Eikon:  ID:nWkr204zTr 
Further company coverage:  ELIC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))